Celebrating Our Company's Great Success at the 13th National Cytopathology Conference of the Chinese Medical Association

On June 12, the 13th National Cytopathology Conference of the Chinese Medical Association opened grandly in Anhui Province. More than 400 pathology experts, directors, and technical specialists from across China and internationally attended this conference. At this conference, our company's independently developed and intellectually proprietary detection system — the "SPICM-DNA Fully Automatic Cell Tumor Screening and Analysis System" — attracted a large number of hospital experts to stop and observe, inquire, and learn more during the exhibition.

At the Heer satellite symposium during this conference, Professor Yu Xiaomeng, a leading domestic cytology expert, gave a keynote introduction of our company's "SPICM-DNA Fully Automatic Cell Tumor Screening and Analysis System's" innovative technology, fully affirmed its significant importance in the field of precancerous screening, and proposed the necessity for wider promotion.

The company's primary goal for this conference was to broaden horizons, open minds, learn from advanced practices, and foster exchange and cooperation. Fully utilizing the opportunity provided by this conference, the company engaged in communication, discussion, and negotiation with the pathology experts, technical specialists, and other attendees to further expand the company's reputation and influence within the industry. At the exhibition venue, company technicians answered every attendee's questions in detail, while also giving live demonstrations of the "SPICM-DNA Fully Automatic Cell Tumor Screening and Analysis System," engaging in in-depth discussions of the technology with distributors, pathology experts, and technical specialists, and receiving unanimous praise from distributors, pathology experts, and technical specialists alike!